okredo logo
none title certification

MB "IVB Pharma Consulting" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data
Financial report background

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
243,928
120,162
80,113
76,079
37,477
70.60
31.19
132,394
23,226
0
155,620
2022
247,936
122,741
84,649
80,275
39,740
85.63
32.38
145,620
41,662
17,171
170,111
2023
223,245
212,614
100,459
95,927
91,359
75.62
42.97
183,659
16,590
0
200,249
unlock data icon

Register and

explore Okredo data
2023
223,245
212,614
100,459
95,927
91,359
75.62
42.97
183,659
16,590
0
200,249
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

223,245 €Descended-10 % *

Sales per employee (€)

212,614 €Ascended73 % *

Profit before tax (€)

100,459 €Ascended19 % *

Net Profit (€)

95,927 €Ascended20 % *

Profit per employee (€)

91,359 €Ascended130 % *

Total profitability (%)

75.62 %Descended-11.69 % *

Net profitability (%)

42.97 %Ascended32.71 % *

Equity (€)

183,659 €Ascended26 % *

Amounts Payable And Liabilities (€)

16,590 €Descended-60 % *

Non-current Assets (€)

0 €Descended-100 % *

CurrentAssets (€)

200,249 €Ascended18 % *

*over the last year starting selected period